MedPath

Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer

Phase 2
Completed
Conditions
Gastric Cancer
Interventions
Procedure: Laparoscopic sentinel node navigation surgery
Registration Number
NCT01441310
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

There are few reports on a dual dye and isotope approach using laparoscopy in gastric cancer sentinel node mapping.

The aim of this study was to evaluate the feasibility of laparoscopic limited gastrectomy with sentinel basin(SB) dissection for gastric cancer using simultaneous indocyanine green (ICG) and 99mTc-antimony sulfur colloid (ASC) injections.

Detailed Description

Prospective phase II clinical trials for sentinel node navigation surgery(SNNS) in early gastric cancer.

Laparoscopic SNNS:

1. ICG and 99mTc-antimony sulfur colloid (ASC) submucosal injection under intraoperative endoscopy

2. Sentinel node basin identification and dissection

3. Sentinel nodes picking in back table

4. Frozen biopsy of sentinel nodes(hematoxylin and eosin staining and immunohistochemistry for cytokeratin)

5. If the sentinel node biopsy by frozen section is negative, limited gastrectomy will be performed or if positive, radical D2 gastrectomy will be performed.

Sample size: 100 cases

Study duration: 5 years( 2year enrollment, 3 year follow-up)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • Age 20-80
  • Informed consent
  • No other malignancies
  • cT1N0 stage gastric cancers < 4cm
  • no allergic history of isotope
Exclusion Criteria
  • Patients eligible for endoscopic submucosal dissection(ESD) with absolute indication

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Laparoscopic sentinel node navigation surgeryLaparoscopic sentinel node navigation surgeryLaparoscopic sentinel node navigation surgery
Primary Outcome Measures
NameTimeMethod
3 Year disease free survivalPostoperative 3 year

Recurrence evaluation by eddoscopy, computed tomography and Positron emission tomography if needed.

Secondary Outcome Measures
NameTimeMethod
Sentinel node detection rate, occurrence of complication ,Qualtity of life and remnant stomach function evaluation.postoperative 1, 3, 6, 12 month

Sentinel node detection rate and occurrence of complication of SNNS using dual method for gastric cancer were evaluated QoL questennaire and remnant stomach function were evaluated for the evaluation of patient's quality of life

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyeonggi, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath